ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,549, issued on Aug. 12, was assigned to Arog Pharmaceuticals Inc. (Plano, Texas).
"Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders" was invented by Vinay K. Jain (Dallas).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes methods for treating a proliferative disorder comprising administering a therapeutically effective amount of crenolanib or a salt thereof in combination with pharmaceutical agent targeting apoptosis pathway proteins wherein the crenolanib and other agent are provided at least one of sequentially or concomitantly in a subject for use in the treatme...